Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
about
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.PCSK9 and Atherosclerosis - Lipids and Beyond.The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review.The Role of Inflammation in Cardiovascular Outcome.Lipoprotein(a): the revenant.Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes.[Impact of lipid metabolism parameters on the development and progression of coronary artery disease : An update].High circulating proprotein convertase subtilisin/Kexin type 9 concentration associates with cardiovascular risk: A meta-analysis of cohort studies.Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort.Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.Circulating PCSK9 is lowered acutely following surgery.Association of Level of Proprotein Convertase Subtilisin/Kexin Type 9 with Intima-Media Thickness in Patients with Familial Hypercholesterolemia.Effective low-density lipoprotein-lowering therapy: Implementation in clinical practice.Circulating proprotein convertase subtilisin-kexin type 9, all-cause mortality, and cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health study.Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome.Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI CohortsSerum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarctionResponse: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)Letter: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
P2860
Q33599961-3A259D47-52FC-436C-9177-F94949E174CCQ33675963-5382985B-49A5-4308-A317-6E1158253D47Q38637552-E2AB4B41-6F0B-4870-8319-1CB4905EE0C3Q39134471-19DC9257-6571-4AAE-8FB0-EF8DDEB8B24BQ40280257-B723C2A8-C4DE-4E6F-A649-C8BD60254A81Q40530815-2F41BF4F-3C2E-46F9-A8A2-DB997D1A75E8Q40740507-D2CEBE97-9D47-44B7-8B56-D0407CE17260Q47139387-2F8F40C5-0563-46B2-B3A4-AD74825D8D30Q47390481-8FAD3A5A-5628-46C9-BF4D-039C488CC359Q47597427-2F9C4546-0147-4152-BA10-E16AC8EBB004Q47613511-92D55DEF-EDEB-4989-9F22-294B0CE698FBQ48178320-E515EC74-57B2-4EEA-BD9A-5A0F5E4FF45FQ48284544-343A0B13-D324-4276-9487-19A331839BB0Q50880816-AF7D6C3B-B223-4492-B873-A8FCF84373A6Q52838034-9C77C46F-8C67-4505-AEA6-2D383F6355BDQ53337735-FB04DEE8-4362-4D0D-8EDF-C5C97C264A7DQ54940707-D08621E5-BDE3-485E-9756-E526E481BA12Q55383088-4E77037B-D59C-4FF9-AB1E-26423F68CA6EQ57821404-DAF7AAC9-D3D6-4801-B48D-C35DAD054D47Q58724610-FF8288B7-8D37-42F6-8B64-FB4902F1345DQ58730027-98B50A1B-FC4A-4BD7-8A3C-D39FEFDA9D83Q58730050-EE6E33E0-B062-4695-A245-38DF8DDDB87F
P2860
Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
@en
type
label
Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
@en
prefLabel
Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
@en
P2093
P2860
P50
P356
P1476
Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
@en
P2093
Baris Gencer
Christian M Matter
François Mach
Nicolas Rodondi
Nicolas Vuilleumier
Roland Klingenberg
Soheila Aghlmandi
P2860
P304
P356
10.1093/EURHEARTJ/EHV637
P50
P577
2015-12-09T00:00:00Z